OX2 THERAPEUTICS
OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors. Its novel CD200 Checkpoint peptide inhibitor activates the immune system through a CD200 activation receptor, enabling healthcare institutes to apply receptor antibodies that permit the immune system army to pass through blood vessel walls and kill cancer activities.
OX2 THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-06-01
Address:
Minneapolis, Minnesota, United States
Country:
United States
Website Url:
http://www.ox2therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
612-309-7653
Total Funding:
649.42 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Current Employees Featured
Founder
Official Site Inspections
http://www.ox2therapeutics.com Semrush global rank: 7.43 M Semrush visits lastest month: 511
- Host name: box2268.bluehost.com
- IP address: 50.87.192.155
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "OX2 Therapeutics"
OX2 Therapeutics | Developing new therapies to turn …
OX2 Therapeutics Receives FDA Approval for Phase I Clinical Trial to Treat High-Grade Glioblastoma with Novel Peptide Checkpoint Inhibitor (CD200AR-L); First-of-Its Kind Peptide Also Being Developed As Platform for Possible Treatment …See details»
OX2 Therapeutics - Crunchbase Company Profile
OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors. Its novel CD200 Checkpoint peptide inhibitor activates the …See details»
OX2 Therapeutics Company Profile | Management and Employees …
Www.ox2therapeutics.com . OX2 Therapeutics Profile and History. OX2 Therapeutics, Inc is a clinical stage, biopharmaceutical company developing new therapies to turn cancers into …See details»
OX2 Therapeutics - VentureRadar
Website: https://ox2therapeutics.com/ Develops cancer therapies utilizing CD200 derived peptide, OX2 inhibitors, and adjuvants to overcome tumor-induced suppression ...See details»
OX2 Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OX2 Therapeutics, Inc. of Minneapolis, MN. Get the latest business insights from Dun & Bradstreet.See details»
OX2 Therapeutics, Inc. | LinkedIn
OX2 Therapeutics, Inc. | 4 followers on LinkedIn.See details»
OX2 Therapeutics - Overview, News & Similar companies - ZoomInfo
Jan 12, 2021 OX2 Therapeutics contact info: Phone number: (612) 309-7653 Website: www.ox2therapeutics.com What does OX2 Therapeutics do? OX2 Therapeutics, Inc is a …See details»
OX2 Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 48820 Kato Road Ste 400B. Fremont, California, 94538, United States. 612-309-7653See details»
OX2 Therapeutics - VentureRadar
OX2 Therapeutics has an exclusive clinical / commercial license grant on the following patents from the University of Minnesota: CD200 Derived... ... Find out more ...See details»
OX2 Therapeutics - Craft
OX2 Therapeutics is a company that specializes in the treatment of primary brain tumors and other solid tumors. Its research and development program is focused on CD200 protein that …See details»
OX2 Therapeutics - PitchBook
OX2 Therapeutics General Information Description. Operator of a healthcare therapeutics company intended to treat primary brain tumors. The company's novel CD200 checkpoint …See details»
OX2 Therapeutics - Company Profile - Tracxn
OX2 Therapeutics - Developer of therapies for treating brain cancers. Raised a total funding of $954K over 2 rounds. Founded by Chris Moertel, Michael Olin and 1 other in the year 2016. …See details»
OX2 Therapeutics, Inc. | OX2 - CAGE.report
Www.ox2therapeutics.com. E-Commerce Website: Contact Person: Jeff Liter County Code (3 digit): 053 Congressional District: 05 Metropolitan Statistical Area: 5120 CAGE Code: ...See details»
OX2 Therapeutics - Contacts, Employees, Board Members
OX2 Therapeutics is a healthcare therapeutics company that focuses on treating brain tumors.See details»
More - OX2 Therapeutics
OX2 Therapeutics has an exclusive clinical / commercial license grant on the following patents from the University of Minnesota. CD200 Derived Peptide Augments Tumor Induced …See details»
OX2 Therapeutics | CipherBio
Explore OX2 Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
OX2 Therapeutics | VentureRadar
Similar Companies: Sun BioPharma USA Privately Held Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and …See details»
Ox2 Therapeutics Company Profile -Sales, Contacts, Competitors – …
Ox2 Therapeutics, Inc. (trade name Ox2) is in the Biotherapeutics business. View competitors, revenue, employees, website and phone number.See details»
OX2 Therapeutics Receives FDA Approval for Phase I Clinical Trial …
Jun 8, 2020 OX2 Therapeutics Receives FDA Approval for Phase I Clinical Trial to Treat High-Grade Glioblastoma with Novel Peptide Checkpoint Inhibitor (CD200AR-L); First-of-Its-Kind …See details»
First AI-powered Drug Candidates Marketplace
Jun 18, 2021 OX2 Therapeutics is a clinical-stage biopharmaceutical company developing new therapies to turn cancers into manageable and potentially curable diseases.See details»